154 related articles for article (PubMed ID: 18535366)
1. Polarization of natural killer T cells towards an NKT2 subpopulation occurs after stimulation with alpha-galactosylceramide and rhG-CSF in aplastic anemia.
Wang Y; Hu X; Guo C; Zhang Q; Peng J; Zhang J; Li L; Zhang T; Xu C
Acta Haematol; 2008; 119(3):178-86. PubMed ID: 18535366
[TBL] [Abstract][Full Text] [Related]
2. [In vitro activation of bone marrow natural killer T cells of aplastic anemia patients].
Wang YX; Xu CG; Ran JL; Wu XC; Sun JH; Wang JD; Guo CS; Liu JL; Kong DX; Dou AX
Zhonghua Xue Ye Xue Za Zhi; 2010 Aug; 31(8):536-9. PubMed ID: 21122333
[TBL] [Abstract][Full Text] [Related]
3. Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.
Ikarashi Y; Iizuka A; Heike Y; Yoshida M; Takaue Y; Wakasugi H
Immunol Lett; 2005 Nov; 101(2):160-7. PubMed ID: 16054231
[TBL] [Abstract][Full Text] [Related]
4. Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells.
van der Vliet HJ; Molling JW; Nishi N; Masterson AJ; Kölgen W; Porcelli SA; van den Eertwegh AJ; von Blomberg BM; Pinedo HM; Giaccone G; Scheper RJ
Cancer Res; 2003 Jul; 63(14):4101-6. PubMed ID: 12874013
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases.
Kojo S; Adachi Y; Keino H; Taniguchi M; Sumida T
Arthritis Rheum; 2001 May; 44(5):1127-38. PubMed ID: 11352245
[TBL] [Abstract][Full Text] [Related]
6. Insufficient ex vivo expansion of Valpha24(+) natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14(+) cells.
Imataki O; Heike Y; Makiyama H; Iizuka A; Ikarashi Y; Ishida T; Wakasugi H; Takaue Y
Cytotherapy; 2008; 10(5):497-506. PubMed ID: 18608348
[TBL] [Abstract][Full Text] [Related]
7. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.
Fujii S; Shimizu K; Kronenberg M; Steinman RM
Nat Immunol; 2002 Sep; 3(9):867-74. PubMed ID: 12154358
[TBL] [Abstract][Full Text] [Related]
8. A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.
Motohashi S; Nagato K; Kunii N; Yamamoto H; Yamasaki K; Okita K; Hanaoka H; Shimizu N; Suzuki M; Yoshino I; Taniguchi M; Fujisawa T; Nakayama T
J Immunol; 2009 Feb; 182(4):2492-501. PubMed ID: 19201905
[TBL] [Abstract][Full Text] [Related]
9. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
Yanagisawa K; Exley MA; Jiang X; Ohkochi N; Taniguchi M; Seino K
Cancer Res; 2006 Dec; 66(23):11441-6. PubMed ID: 17145891
[TBL] [Abstract][Full Text] [Related]
10. Expansion of human Valpha24+ NKT cells by repeated stimulation with KRN7000.
Rogers PR; Matsumoto A; Naidenko O; Kronenberg M; Mikayama T; Kato S
J Immunol Methods; 2004 Feb; 285(2):197-214. PubMed ID: 14980434
[TBL] [Abstract][Full Text] [Related]
11. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide.
Chiba A; Oki S; Miyamoto K; Hashimoto H; Yamamura T; Miyake S
Arthritis Rheum; 2004 Jan; 50(1):305-13. PubMed ID: 14730629
[TBL] [Abstract][Full Text] [Related]
12. Efficient ex vivo expansion of Valpha24+ NKT cells derived from G-CSF-mobilized blood cells.
Imataki O; Heike Y; Ishida T; Takaue Y; Ikarashi Y; Yoshida M; Wakasugi H; Kakizoe T
J Immunother; 2006; 29(3):320-7. PubMed ID: 16699375
[TBL] [Abstract][Full Text] [Related]
13. Alpha-galactosylceramide-driven expansion of human natural killer T cells is inhibited by prednisolone treatment.
Johansson U; Macey MG; Kenny D; Provan D; Newland AC
Br J Haematol; 2004 May; 125(3):400-4. PubMed ID: 15086423
[TBL] [Abstract][Full Text] [Related]
14. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
Giaccone G; Punt CJ; Ando Y; Ruijter R; Nishi N; Peters M; von Blomberg BM; Scheper RJ; van der Vliet HJ; van den Eertwegh AJ; Roelvink M; Beijnen J; Zwierzina H; Pinedo HM
Clin Cancer Res; 2002 Dec; 8(12):3702-9. PubMed ID: 12473579
[TBL] [Abstract][Full Text] [Related]
15. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.
Van Kaer L
Nat Rev Immunol; 2005 Jan; 5(1):31-42. PubMed ID: 15630427
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor modulates alpha-galactosylceramide-responsive human Valpha24+Vbeta11+NKT cells.
Crough T; Nieda M; Nicol AJ
J Immunol; 2004 Oct; 173(8):4960-6. PubMed ID: 15470038
[TBL] [Abstract][Full Text] [Related]
17. [Ex vivo expansion of Valpha24 natural killer T cells with alpha-galactosylceramide].
Huang Y; Jiang EL; Zhou Z; He Y; Wang M; Liu QG; Zhai WJ; Han MZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):315-20. PubMed ID: 16038267
[TBL] [Abstract][Full Text] [Related]
18. Ligand-activated natural killer T lymphocytes promptly produce IL-3 and GM-CSF in vivo: relevance to peripheral myeloid recruitment.
Leite-de-Moraes MC; Lisbonne M; Arnould A; Machavoine F; Herbelin A; Dy M; Schneider E
Eur J Immunol; 2002 Jul; 32(7):1897-904. PubMed ID: 12115609
[TBL] [Abstract][Full Text] [Related]
19. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia.
Dubey S; Shukla P; Nityanand S
Ann Hematol; 2005 Sep; 84(9):572-7. PubMed ID: 15815907
[TBL] [Abstract][Full Text] [Related]
20. A distinct subset of natural killer T cells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity.
Lee KA; Kang MH; Lee YS; Kim YJ; Kim DH; Ko HJ; Kang CY
Cell Immunol; 2008 Jan; 251(1):50-5. PubMed ID: 18423430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]